As of Nov 17
| 0.00 / 0.00%|
The 16 analysts offering 12-month price forecasts for AbbVie have a median target of 100.00, with a high estimate of 115.00 and a low estimate of 66.00. The median estimate represents a +6.83% increase from the last price of 93.61.
The current consensus among 19 polled investment analysts is to Buy stock in AbbVie. This rating has held steady since November, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.